Global Organ Preservation Solutions Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Organ Preservation Solutions Revenue
• 1.4 Market by Type
  • 1.4.1 Global Organ Preservation Solutions Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Viaspan
  • 1.4.3 Custodial
  • 1.4.4 Renograf
  • 1.4.5 Hypothermosol
  • 1.4.6 Perfadex
  • 1.4.7 Lifor
  • 1.4.8 HBS Solution
  • 1.4.9 siRNA Transplant Solutions
  • 1.4.10 Others
• 1.5 Market by Application
  • 1.5.1 Global Organ Preservation Solutions Market Share by Application: 2020 VS 2026
  • 1.5.2 Hypothermic Perfusion Preservation (HPP)
  • 1.5.3 Static Cold Storage (SCS)
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Organ Preservation Solutions Market Perspective (2015-2026)
• 2.2 Global Organ Preservation Solutions Growth Trends by Regions
  • 2.2.1 Organ Preservation Solutions Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Organ Preservation Solutions Historic Market Share by Regions (2015-2020)
  • 2.2.3 Organ Preservation Solutions Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Organ Preservation Solutions Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Organ Preservation Solutions Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Organ Preservation Solutions Players by Market Size
  • 3.1.1 Global Top Organ Preservation Solutions Players by Revenue (2015-2020)
  • 3.1.2 Global Organ Preservation Solutions Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Organ Preservation Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Organ Preservation Solutions Market Concentration Ratio
  • 3.2.1 Global Organ Preservation Solutions Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Organ Preservation Solutions Revenue in 2019
• 3.3 Organ Preservation Solutions Key Players Head office and Area Served
• 3.4 Key Players Organ Preservation Solutions Product Solution and Service
• 3.5 Date of Enter into Organ Preservation Solutions Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Organ Preservation Solutions Historic Market Size by Type (2015-2020)
• 4.2 Global Organ Preservation Solutions Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Organ Preservation Solutions Market Size by Application (2015-2020)
• 5.2 Global Organ Preservation Solutions Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Organ Preservation Solutions Market Size (2015-2020)
• 6.2 Organ Preservation Solutions Key Players in North America (2019-2020)
• 6.3 North America Organ Preservation Solutions Market Size by Type (2015-2020)
• 6.4 North America Organ Preservation Solutions Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Organ Preservation Solutions Market Size (2015-2020)
• 7.2 Organ Preservation Solutions Key Players in Europe (2019-2020)
• 7.3 Europe Organ Preservation Solutions Market Size by Type (2015-2020)
• 7.4 Europe Organ Preservation Solutions Market Size by Application (2015-2020)

8 China

• 8.1 China Organ Preservation Solutions Market Size (2015-2020)
• 8.2 Organ Preservation Solutions Key Players in China (2019-2020)
• 8.3 China Organ Preservation Solutions Market Size by Type (2015-2020)
• 8.4 China Organ Preservation Solutions Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Organ Preservation Solutions Market Size (2015-2020)
• 9.2 Organ Preservation Solutions Key Players in Japan (2019-2020)
• 9.3 Japan Organ Preservation Solutions Market Size by Type (2015-2020)
• 9.4 Japan Organ Preservation Solutions Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Organ Preservation Solutions Market Size (2015-2020)
• 10.2 Organ Preservation Solutions Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Organ Preservation Solutions Market Size by Type (2015-2020)
• 10.4 Southeast Asia Organ Preservation Solutions Market Size by Application (2015-2020)

11 India

• 11.1 India Organ Preservation Solutions Market Size (2015-2020)
• 11.2 Organ Preservation Solutions Key Players in India (2019-2020)
• 11.3 India Organ Preservation Solutions Market Size by Type (2015-2020)
• 11.4 India Organ Preservation Solutions Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Organ Preservation Solutions Market Size (2015-2020)
• 12.2 Organ Preservation Solutions Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Organ Preservation Solutions Market Size by Type (2015-2020)
• 12.4 Central & South America Organ Preservation Solutions Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Dr. Franz Köhler Chemie
  • 13.1.1 Dr. Franz Köhler Chemie Company Details
  • 13.1.2 Dr. Franz Köhler Chemie Business Overview
  • 13.1.3 Dr. Franz Köhler Chemie Organ Preservation Solutions Introduction
  • 13.1.4 Dr. Franz Köhler Chemie Revenue in Organ Preservation Solutions Business (2015-2020))
  • 13.1.5 Dr. Franz Köhler Chemie Recent Development
• 13.2 Teva Pharmaceutical Industries Ltd.
  • 13.2.1 Teva Pharmaceutical Industries Ltd. Company Details
  • 13.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
  • 13.2.3 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Introduction
  • 13.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
• 13.3 Lifeline Scientific
  • 13.3.1 Lifeline Scientific Company Details
  • 13.3.2 Lifeline Scientific Business Overview
  • 13.3.3 Lifeline Scientific Organ Preservation Solutions Introduction
  • 13.3.4 Lifeline Scientific Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.3.5 Lifeline Scientific Recent Development
• 13.4 Bristol-Myers Squibb
  • 13.4.1 Bristol-Myers Squibb Company Details
  • 13.4.2 Bristol-Myers Squibb Business Overview
  • 13.4.3 Bristol-Myers Squibb Organ Preservation Solutions Introduction
  • 13.4.4 Bristol-Myers Squibb Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.4.5 Bristol-Myers Squibb Recent Development
• 13.5 BioLife Solutions, Inc.
  • 13.5.1 BioLife Solutions, Inc. Company Details
  • 13.5.2 BioLife Solutions, Inc. Business Overview
  • 13.5.3 BioLife Solutions, Inc. Organ Preservation Solutions Introduction
  • 13.5.4 BioLife Solutions, Inc. Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.5.5 BioLife Solutions, Inc. Recent Development
• 13.6 XVIVO Perfusion AB
  • 13.6.1 XVIVO Perfusion AB Company Details
  • 13.6.2 XVIVO Perfusion AB Business Overview
  • 13.6.3 XVIVO Perfusion AB Organ Preservation Solutions Introduction
  • 13.6.4 XVIVO Perfusion AB Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.6.5 XVIVO Perfusion AB Recent Development
• 13.7 ToleroTech, Inc
  • 13.7.1 ToleroTech, Inc Company Details
  • 13.7.2 ToleroTech, Inc Business Overview
  • 13.7.3 ToleroTech, Inc Organ Preservation Solutions Introduction
  • 13.7.4 ToleroTech, Inc Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.7.5 ToleroTech, Inc Recent Development
• 13.8 CryoLife, Inc.
  • 13.8.1 CryoLife, Inc. Company Details
  • 13.8.2 CryoLife, Inc. Business Overview
  • 13.8.3 CryoLife, Inc. Organ Preservation Solutions Introduction
  • 13.8.4 CryoLife, Inc. Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.8.5 CryoLife, Inc. Recent Development
• 13.9 Claris Lifesciences Limited
  • 13.9.1 Claris Lifesciences Limited Company Details
  • 13.9.2 Claris Lifesciences Limited Business Overview
  • 13.9.3 Claris Lifesciences Limited Organ Preservation Solutions Introduction
  • 13.9.4 Claris Lifesciences Limited Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.9.5 Claris Lifesciences Limited Recent Development
• 13.10 BioTime, Inc.
  • 13.10.1 BioTime, Inc. Company Details
  • 13.10.2 BioTime, Inc. Business Overview
  • 13.10.3 BioTime, Inc. Organ Preservation Solutions Introduction
  • 13.10.4 BioTime, Inc. Revenue in Organ Preservation Solutions Business (2015-2020)
  • 13.10.5 BioTime, Inc. Recent Development
• 13.11 21st Century Medicine
  • 10.11.1 21st Century Medicine Company Details
  • 10.11.2 21st Century Medicine Business Overview
  • 10.11.3 21st Century Medicine Organ Preservation Solutions Introduction
  • 10.11.4 21st Century Medicine Revenue in Organ Preservation Solutions Business (2015-2020)
  • 10.11.5 21st Century Medicine Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer